Search Results - "Burke, Robert"

Refine Results
  1. 1

    Axon degeneration in Parkinson's disease by Burke, Robert E., O'Malley, Karen

    Published in Experimental neurology (01-08-2013)
    “…Parkinson's disease (PD) is the most common neurodegenerative disease of the basal ganglia. Like other adult-onset neurodegenerative disorders, it is without a…”
    Get full text
    Journal Article
  2. 2

    Retrograde Axonal Degeneration in Parkinson Disease by Tagliaferro, Patricia, Burke, Robert E

    Published in Journal of Parkinson's disease (30-03-2016)
    “…In spite of tremendous research efforts we have not yet achieved two of our principal therapeutic goals in the treatment of Parkinson's disease (PD), to…”
    Get more information
    Journal Article
  3. 3

    Regulation of Presynaptic Neurotransmission by Macroautophagy by Hernandez, Daniela, Torres, Ciara A., Setlik, Wanda, Cebrián, Carolina, Mosharov, Eugene V., Tang, Guomei, Cheng, Hsiao-Chun, Kholodilov, Nikolai, Yarygina, Olga, Burke, Robert E., Gershon, Michael, Sulzer, David

    Published in Neuron (Cambridge, Mass.) (26-04-2012)
    “…mTOR is a regulator of cell growth and survival, protein synthesis-dependent synaptic plasticity, and autophagic degradation of cellular components. When…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Clinical progression in Parkinson disease and the neurobiology of axons by Cheng, Hsiao-Chun, Ulane, Christina M., Burke, Robert E.

    Published in Annals of neurology (01-06-2010)
    “…Despite tremendous growth in recent years in our knowledge of the molecular basis of Parkinson disease (PD) and the molecular pathways of cell injury and…”
    Get full text
    Journal Article
  7. 7

    Evaluating the relationship between facility Age-Friendly recognition and subsequent facility-free days in older Veterans by Burke, Robert E, Tjader, Andrew, Church, Kimberly, Munro, Shannon, Rose, Liam

    “…Thousands of health systems have been recognized as "Age-Friendly" for implementing geriatric care practices aligned with the "4Ms" (What Matters, Medication,…”
    Get full text
    Journal Article
  8. 8

    Outcomes of post‐acute care in skilled nursing facilities in Medicare beneficiaries with and without a diagnosis of dementia by Burke, Robert E., Xu, Yao, Ritter, Ashley Z.

    “…Abstract Background More than 600,000 Medicare beneficiaries with a diagnosis of dementia are discharged to skilled nursing facilities (SNFs) after…”
    Get full text
    Journal Article
  9. 9
  10. 10

    ProteoWizard: open source software for rapid proteomics tools development by Kessner, Darren, Chambers, Matt, Burke, Robert, Agus, David, Mallick, Parag

    Published in Bioinformatics (01-11-2008)
    “…The ProteoWizard software project provides a modular and extensible set of open-source, cross-platform tools and libraries. The tools perform proteomics data…”
    Get full text
    Journal Article
  11. 11

    Highly Scalable, Atomically Thin WSe2 Grown via Metal–Organic Chemical Vapor Deposition by Eichfeld, Sarah M, Hossain, Lorraine, Lin, Yu-Chuan, Piasecki, Aleksander F, Kupp, Benjamin, Birdwell, A. Glen, Burke, Robert A, Lu, Ning, Peng, Xin, Li, Jie, Azcatl, Angelica, McDonnell, Stephen, Wallace, Robert M, Kim, Moon J, Mayer, Theresa S, Redwing, Joan M, Robinson, Joshua A

    Published in ACS nano (24-02-2015)
    “…Tungsten diselenide (WSe2) is a two-dimensional material that is of interest for next-generation electronic and optoelectronic devices due to its direct…”
    Get full text
    Journal Article
  12. 12

    How Hospital Clinicians Select Patients for Skilled Nursing Facilities by Burke, Robert E., Lawrence, Emily, Ladebue, Amy, Ayele, Roman, Lippmann, Brandi, Cumbler, Ethan, Allyn, Rebecca, Jones, Jacqueline

    “…Objective To understand how hospital‐based clinicians evaluate older adults in the hospital and decide who will be transferred to a skilled nursing facility…”
    Get full text
    Journal Article
  13. 13

    High Luminescence Efficiency in MoS2 Grown by Chemical Vapor Deposition by Amani, Matin, Burke, Robert A, Ji, Xiang, Zhao, Peida, Lien, Der-Hsien, Taheri, Peyman, Ahn, Geun Ho, Kirya, Daisuke, Ager, Joel W, Yablonovitch, Eli, Kong, Jing, Dubey, Madan, Javey, Ali

    Published in ACS nano (26-07-2016)
    “…One of the major challenges facing the rapidly growing field of two-dimensional (2D) transition metal dichalcogenides (TMDCs) is the development of growth…”
    Get full text
    Journal Article
  14. 14

    Interventions to decrease hospital readmissions: keys for cost-effectiveness by Burke, Robert E, Coleman, Eric A

    Published in JAMA internal medicine (22-04-2013)
    “…Hospitals began paying financial penalties for high-risk-adjusted 30-day readmission rates for certain diagnoses in October 2012. Physician leaders seeking to…”
    Get more information
    Journal Article
  15. 15

    VA nursing home compare metrics as an indicator of skilled nursing facility quality for veterans by Manges, Kirstin A., Medvedeva, Elina, Ersek, Mary, Burke, Robert E.

    “…Background The Veterans Administration (VA) provides several post‐acute care (PAC) options for Veterans, including VA‐owned nursing homes (called Community…”
    Get full text
    Journal Article
  16. 16

    Monolayer Molybdenum Disulfide Transistors with Single-Atom-Thick Gates by Zhu, Yibo, Li, Yijun, Arefe, Ghidewon, Burke, Robert A, Tan, Cheng, Hao, Yufeng, Liu, Xiaochi, Liu, Xue, Yoo, Won Jong, Dubey, Madan, Lin, Qiao, Hone, James C

    Published in Nano letters (13-06-2018)
    “…Two-dimensional transition-metal dichalcogenides (TMDs) are unique candidates for the development of next-generation electronic devices. However, the large…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Systems Approach Is Needed for In-Hospital Mobility: A Qualitative Metasynthesis of Patient and Clinician Perspectives by Stutzbach, Julie, Jones, Jacqueline, Taber, Anna, Recicar, John, Burke, Robert E., Stevens-Lapsley, Jennifer

    “…To describe how different key stakeholders (ie, interprofessional clinical care team and patients) perceive their role in promoting in-hospital mobility by…”
    Get full text
    Journal Article
  19. 19

    Disease Modification for Parkinson's Disease: Axonal Regeneration and Trophic Factors by Kordower, Jeffrey H., Burke, Robert E.

    Published in Movement disorders (01-05-2018)
    “…ABSTRACT Disease modification and structural neuroprotection have been the holy grail for Parkinson's disease (PD) experimental therapeutics. Theoretically,…”
    Get full text
    Journal Article
  20. 20